La vendita allo scoperto per CureVac dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di CureVac. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

CureVac (NASDAQ:CVAC) Azioni, Report sulle vendite allo scoperto

CureVac

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

Large Cap

News

Health Care

General

CVAC

MRNA

NVAX

Quali sono le aziende pronte a rispondere all&#39;emergenza e come potrebbe impattare sul mercato azionario? Ecco i dettagli.

Allarme influenza aviaria: nuovo caso in USA. Ecco 4 azioni da tenere d&#39;occhio

CureVac NV

Personal-finance guru Dave Ramsey dismissed Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) investors as &#8220;stupid,&#8221; adding, &#8220;you're gonna lose your money&#8221; during a February 2014 radio show, when the cryptocurrency closed at $549.26 per coin.
Eleven years later, Bitcoin set a <a href="https://www.benzinga.com/25/05/45557202/nvidia-founder-jensen-huang-surpassed-by-satoshi-nakamoto-in-personal-wealth-as-bitcoin-tops-111000">fresh record</a> above $111,000 on Thursday, May 22, 2025, after U.S. regulatory gains and heavy exchange-traded-fund inflows lifted demand.
What Happened: Bitcoin's overnight break of the psychologically important <a href="https://www.benzinga.com/25/05/45556607/bitcoin-clocks-110000-ethereum-dogecoin-extend-gains-experienced-trader-peter-brandt-speculates-btc-to-enter-this-range-by-august-end">$110,000 level</a> pushed the token to as high as $111,861 before noon in New York, eclipsing the $109,241 mark set on Donald Trump's inauguration day.
Real-time data show 24-hour trading volume swelling more than 75 percent to roughly $92 billion, signaling surging speculative interest. The milestone was a catalyst that vaulted pseudonymous Bitcoin creator Satoshi Nakamoto past Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) chief Jensen Huang on the Bloomberg billionaire index.
See also: <a href="https://www.benzinga.com/government/regulations/25/05/45557042/unicoin-ceo-alex-konanykhin-calls-sec-fraud-charges-blatantly-false-vows-to-fight-in-court">Unicoin CEO Alex Konanykhin Calls SEC Fraud Charges &#8216;Blatantly False,&#8217; Vows To Fight In Court</a>
The Math: A listener ignoring Ramsey's warning and plowing $1,000 into Bitcoin at the Feb. 28, 2014, close would have bought 1.82 BTC.
At today's intraday high of $111,000, that stake is worth about $202,000 — a 20,100% gain and a 202-fold return on capital.
For the sake of comparison, the price of Gold Futures on Feb. 28, 2014, according to Yahoo Finance data, was $1,331.60 per ounce. Fast-forward to May 22, and Gold Futures are valued at $3,329.10 at the time of writing. That amounts to an increase of 150% over time.
Price Action: At the time of writing, BTC was exchanging hands at $110,664.40. up 0.97% in the last 24 hours, <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">according to data from Benzinga Pro</a>.
Read next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45556899/from-amazon-to-warren-buffetts-berkshire-hathawaybitcoin-is-now-bigger-than-these-wall-street-titans">From Warren Buffett&#8217;s Berkshire Hathaway To Jeff Bezos&#8217; Amazon — Bitcoin Is Now Outshining These Wall Street Titans</a></li>
</ul>
Photo Courtesy: Yalcin Sonat on Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

NVDA

If You Invested $1,000 In Bitcoin When Dave Ramsey Called Fans Of The Crypto 'Stupid,' Here's How Much You'd Have Today

WIIM

LUMN

Lumen Technologies shares are trading higher after the company announced the sale of its consumer fiber-to-the-home business to AT&T for $5.75 billion in cash.

URBN

Urban Outfitters shares are trading higher following better-than-expected Q1 financial results.

BITF

CLSK

COIN

HIVE

MARA

MSTR

RIOT

Shares of crypto-linked stocks and Bitcoin miners are trading higher after Bitcoin reached a new all-time high, rising above $110,000.

Shares of health insurance stocks are trading lower after CMS announced a strategy to enhance and accelerate Medicare Advantage audits.

The State Department&#8217;s Bureau of Population, Refugees and Migration will assume leadership of U.S. overseas disaster response operations from the dismantled U.S. Agency for International Development, raising concerns among disaster relief experts about the office&#8217;s preparedness for managing international humanitarian crises.
What Happened: The Bureau of Population, Refugees and Migration (PRM) is taking over foreign disaster response duties from USAID&#8217;s Bureau of Humanitarian Assistance, according to excerpts from an internal State Department cable, Reuters <a href="https://www.reuters.com/world/us/state-department-refugee-office-assume-usaids-disaster-aid-role-says-cable-2025-05-22/">reported</a>. The cable, sent to diplomatic posts worldwide this week, authorizes up to $100,000 for initial disaster responses with PRM approval.
Only 20 experts from USAID&#8217;s original 525-person disaster response team are being transferred to PRM, according to a source familiar with the matter. Jeremy Konyndyk, former director of the Office of U.S. Foreign Disaster Relief and current president of Refugees International, called the arrangement &#8220;ridiculous,&#8221; stating that &#8220;PRM is not an operational entity&#8221; and lacks disaster response capabilities.
The transition follows USAID&#8217;s dismantlement, overseen by Elon Musk as part of President Trump&#8217;s government reduction initiative. Most of USAID&#8217;s 10,000 staff have been placed on administrative leave, facing termination, with thousands of contractors already fired and billions in humanitarian programs canceled.
See Also: <a href="https://www.benzinga.com/tech/25/05/45558772/google-and-character-ai-sued-after-teen-dies-following-interaction-with-game-of-thrones-themed-chatbot-judge-says-free-speech-defense-not-acceptable">Google And Character.AI Sued After Teen Dies Following Interaction With &#8216;Game Of Thrones&#8217;-Themed Chatbot — Judge Says Free Speech Defense Not Acceptable</a>
Why It Matters: The restructuring threatens America&#8217;s disaster response capabilities as the Caribbean hurricane season approaches. Konyndyk warned the U.S. can no longer mobilize its world-leading Disaster Assistance Response Teams (DARTs), stating the PRM cannot replicate these specialized units&#8217; operational mechanics.
The policy shift extends beyond international disasters. The <a href="https://www.benzinga.com/news/25/04/44972378/trump-administration-denies-federal-disaster-aid-to-tornado-stricken-arkansas-pushing-responsibility-to-states">Trump administration denied federal disaster aid to tornado-stricken Arkansas</a> in April, pushing responsibility to states following executive orders redirecting disaster recovery from federal to local authorities. Arkansas Governor Sarah Huckabee Sanders appealed the denial, warning of &#8220;significant challenges&#8221; without federal assistance.
Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) co-founder Bill Gates challenged the USAID dismantlement, questioning whether <a href="https://www.benzinga.com/news/25/02/43617113/bill-gates-challenges-elon-musk-led-doge-approach-to-shutting-down-usaid-asks-if-it-fits-american-value-system?utm_source=chatgpt.com">shuttering the agency aligns with American values</a> given its role in keeping &#8220;tens of millions of Africans alive&#8221; with just &#8220;half a percent of the budget.&#8221; Secretary of State Marco Rubio, now USAID&#8217;s acting director, defended restructuring efforts, claiming the agency had evolved beyond U.S. national interests.
The administration&#8217;s broader disaster policy changes include plans to abolish FEMA, the agency responsible for billions in annual disaster management assistance, fundamentally altering America&#8217;s humanitarian response infrastructure.
Read Also:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45558758/as-unitedhealth-group-lost-an-unthinkable-140-billion-in-market-cap-since-april-analysts-weigh-in-on-the-path-ahead">As UnitedHealth Wipes Out &#8216;Unthinkable&#8217; $140 Billion In Market Value Since April, Analysts Weigh In On The Road Ahead</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: QINQIE99 / Shutterstock.com

Politics

Global

MSFT

State Department Refugee Office Takes Over Overseas Disaster Response From Dismantled USAID, Raising Expert Concerns

SNOW

Snowflake shares are trading higher after the company reported better-than-expected Q1 financial results.

HC Wainwright &amp; Co. analyst Robert Burns reiterates BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) with a Buy and maintains $134 price target.

Price Target

Reiteration

Analyst Ratings

BNTX

HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $134 Price Target

Health and Human Services Secretary Robert F. Kennedy Jr. faces mounting pressure from Republican lawmakers and farming communities as his highly anticipated &#8220;Make America Healthy Again&#8221; report approaches Thursday&#8217;s release, with glyphosate pesticide regulations emerging as the primary flashpoint between public health advocates and agricultural interests.
What Happened: The MAHA Commission report, mandated by President Donald Trump within 100 days to analyze childhood disease factors, has sparked preemptive opposition from 79 Republican lawmakers representing farming states, <a href="https://apnews.com/article/rfk-jr-kennedy-farmers-maha-trump-pesticides-5d5a83bde6b88290cf9c3536e74523be">according</a> to AP. Iowa Republican Sen. Chuck Grassley warned Wednesday that farmers have expressed concerns about being excluded from the report&#8217;s input process.
Kennedy addressed Senate Appropriations Committee concerns from Mississippi Republican Sen. Cindy Hyde-Smith, stating &#8220;there&#8217;s not a single word in them that should worry the American farmer&#8221; and promising not to &#8220;jeopardize that business model.&#8221; The commission, established by Trump&#8217;s February executive order, was tasked with examining prescription drugs, chemicals, and food ingredients affecting children.
The report comes alongside a proposed $500 million budget boost for Kennedy&#8217;s MAHA initiative, while simultaneously cutting infectious disease prevention, maternal health, and medical research programs. Kennedy supporters, including 360 MAHA advocates and former campaign staffers, have submitted pesticide studies pressing for chemical industry accountability.
See Also: <a href="https://www.benzinga.com/25/05/45558200/advance-auto-parts-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">Advance Auto Parts Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a>
Why It Matters: The report&#8217;s potential glyphosate restrictions could significantly impact agricultural productivity and food company operations. Kennedy&#8217;s broader MAHA agenda has already influenced restaurant industry practices, with Biglari Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BH#NASDAQ">BH</a>) subsidiary Steak &#8216;n Shake switching from seed oils to beef tallow for French fries, earning Kennedy&#8217;s public praise for <a href="https://www.benzinga.com/general/restaurants/25/03/44280041/rfk-jr-thanks-steak-n-shake-for-rfking-the-french-fries-restaurant-goes-all-in-on-make-america-healthy-again">&#8220;RFKing the French fries.&#8221;</a>
Other restaurant chains, including Sweetgreen Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>), Bloomin&#8217; Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>)-owned Outback Steakhouse, and Restaurant Brands International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>)-owned Popeyes, have initiated similar transitions. Kennedy has scheduled meetings with food giants PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) and General Mills Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) to <a href="https://www.benzinga.com/markets/equities/25/03/44209953/rfk-jr-takes-on-food-giants-calls-meeting-with-pepsico-and-general-mills">address processed food concerns.</a>
The MAHA initiative&#8217;s budget proposal threatens the <a href="https://www.benzinga.com/personal-finance/25/05/45522362/we-have-no-details-says-food-program-director-as-trumps-maha-boxes-threaten-730000-seniors-grocery-lifeline">$425 million Commodity Supplemental Food Program</a>, potentially affecting 730,000 seniors&#8217; grocery access through replacement &#8220;MAHA boxes.&#8221; Food program directors report logistical challenges and communication gaps, with Connecticut Foodshare experiencing 34 canceled federal shipments affecting over 600 food banks statewide.
The World Health Organization classifies glyphosate as a probable human carcinogen, while farmers argue it remains essential for weed control without excessive soil tilling, creating a regulatory tension between public health priorities and agricultural economics.
Read Also:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45557944/baidus-apollo-go-enters-dubai-and-abu-dhabi-ceo-robin-li-touts-global-robotaxi-lead-with-1-4-million-rides-in-q1">Baidu&#8217;s Apollo Go Enters Dubai And Abu Dhabi, CEO Robin Li Touts Global Robotaxi Lead With 1.4 Million Rides In Q1</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

BLMN

RFK Jr.'s 'Make America Healthy Again' Report Stirs GOP, Farmers Over Glyphosate Concerns Ahead Of Release

Embecta Corp. ("embecta"; "The Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NASDAQ">EMBC</a>), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today to showcase its phased approach for value creation and present its long range financial plan ("LRP").
"Our Investor Day will provide a comprehensive view of our roadmap for transitioning embecta to growth. We look forward to sharing how we are positioning embecta for long-term success in an evolving healthcare landscape," said Dev Kurdikar, President and Chief Executive Officer. "Today, we reiterate our commitment to maintaining our leadership in insulin injection while outlining our long term vision to transform embecta into a more broad-based medical supplies company, paving the way toward a life unlimited for all."
Strategic Priorities embecta's core insulin injection business has long provided a stable, recurring, and geographically diversified revenue base with an attractive margin profile. Following a successful three-year effort to establish embecta as an independent, standalone organization, the Company is currently focused on three strategic priorities aimed at positioning embecta for sustainable, long-term success:
<ul>
<li>Strengthening the core business, which includes executing a seamless brand transition to ensure embecta's identity resonates globally while maintaining the trust of customers. At the same time, the company is continuing to identify opportunities within its core portfolio that bolster its leadership position in injection devices. &nbsp;</li>
<li>Expanding the Company's product portfolio through the introduction of products that leverage embecta's expertise in high-volume manufacturing and the strength of its global commercial channel. &nbsp;</li>
<li>Increasing financial flexibility by generating cost savings through operational efficiencies and prioritizing debt reduction, thereby enhancing the Company's financial agility and ability to make future investments. &nbsp;</li>
</ul>
Fiscal Year 2025 Financial Guidance embecta today reaffirmed its fiscal year 2025 guidance, originally provided in conjunction with its second quarter of fiscal 2025 financial results announced on May 9, 2025.
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Dollars in millions, except percentages and per share data</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Reported Revenues</td>
<td>$1,073 - $1,090</td>
</tr>
<tr>
<td>Reported Revenue Growth (%)</td>
<td>(4.4)% - (2.9)%</td>
</tr>
<tr>
<td>Impact of F/X (%)</td>
<td>(0.8%)</td>
</tr>
<tr>
<td>Impact of Italian Payback Measure (1) (%)</td>
<td>0.4%</td>
</tr>
<tr>
<td>Adjusted Constant Currency Revenue Growth (%)</td>
<td>(4.0)% - (2.5)%</td>
</tr>
<tr>
<td>Adjusted Gross Margin (%)</td>
<td>62.75% - 63.75%</td>
</tr>
<tr>
<td>Adjusted Operating Margin (%)</td>
<td>29.75% - 30.75%</td>
</tr>
<tr>
<td>Adjusted Earnings per Diluted Share</td>
<td>$2.70 - $2.90</td>
</tr>
<tr>
<td>Adjusted EBITDA Margin (%)</td>
<td>36.25% - 37.25%</td>
</tr>
</tbody>
</table>
</figure>
(1) Reflects the recognition of incremental Italian payback accruals resulting from the two July 22, 2024 rulings by the Constitutional Court of Italy relating to certain prior years since 2015 recorded in Revenues. &nbsp;
Long Range Financial Plan embecta today announced its long range financial plan for fiscal 2025 through fiscal 2028.
Over this period, the Company expects to:
<ul>
<li>Maintain a flattish constant currency revenue CAGR</li>
<li>Achieve an adjusted operating margin of approximately 28% to 30%</li>
<li>Generate approximately $600 million of cumulative free cash flow(1)</li>
<li>Repay between $450 million and $500 million of debt</li>
</ul>

Guidance

EMBC

Embecta Reaffirms 2025 Outlook With Up to $1.09B Revenue, Unveils Long-Term Plan to Cut $500M Debt

Earnings

Earnings Beats

Earnings Misses

CORRECTION: Toronto-Dominion Bank Q2 Adj. EPS $1.37 Beats $1.24 Estimate, Sales $10.54B Miss $10.74B Estimate

Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) affirms FY2025 Adj EPS guidance from $1.50-$2.50 to $1.50-$2.50 vs $1.55 analyst estimate. Affirms FY2025 sales outlook from $8.40 billion-$8.60 billion to $8.40 billion-$8.60 billion vs $8.46 billion estimate.

Advance Auto Parts Affirms FY2025 Adj EPS Guidance of $1.50-$2.50 vs $1.55 Est; Affirms FY2025 Sales Guidance of $8.40B-$8.60B vs $8.46B Est

Needham analyst Joseph Stringer reiterates Vir Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIR#NASDAQ">VIR</a>) with a Buy and maintains $14 price target.

Needham Reiterates Buy on Vir Biotechnology, Maintains $14 Price Target

Chinese autonomous vehicle technology company Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) has been on a hot streak, with the stock rallying 315% over the past month, following a string of positive catalysts in recent weeks.
What Happened: During its <a href="https://in.benzinga.com/news/earnings/25/05/45514486/chinas-pony-ai-robotaxi-revenue-jumps-200-eyes-1000-vehicle-fleet">first quarter earnings</a> call on Tuesday, the company confirmed its partnership with Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) aimed at bringing Pony&#8217;s robotaxi platform to international markets.
&#8220;We recently partnered with Uber, which will enable users to access our robotaxi service directly through Uber&#8217;s platform,&#8221; said CEO James Peng. &#8220;The partnership is expected to first launch in a key market in the Middle East later this year with the goal of scaling deployments to additional international markets in the future.&#8221;
The company is now rapidly expanding outside its home base in China, having secured a Level 4 robotaxi testing permit in Luxembourg and initiated road testing in Seoul's Gangnam District. 
See Also: <a href="https://www.benzinga.com/25/05/45556328/jeff-bezos-shrugged-off-dot-com-hype-in-1999-betting-amazons-future-on-customer-obsession-internet-shminternet-that-doesnt-matter-he-said-theres-never-any-conflict-between-customers-and-shareholders-interests-and-walmart-should-say-the-same">Jeff Bezos At Peak Dot-Com Hype Identified A Winning Strategy That Made Amazon Into A 2 Trillion Success Story Today: &#8216;Internet, Shminternet … That Doesn&#8217;t Matter&#8217;</a>
&#8220;These successes have provided us with valuable experience as we explore future opportunities beyond the China market,&#8221; Peng noted.
During the call, the company highlighted its resilience to tariffs and supply-chain disruptions, citing its &#8220;localized strategy.&#8221; CFO Liu Wang said, &#8220;The majority of our supply chain is domestically sourced,&#8221; adding that they enhanced their &#8220;supply chain resilience in response to the evolving geopolitical landscape.&#8221;
The rally has also been in response to the Pony&#8217;s growing scale, with the company reaffirming its target to grow the Gen7 fleet to 1,000 vehicles by year-end.
&#8220;Given the structural efficiency advantages of the Gen seven robotaxis, we have [a] clear line of sight to breakeven and long-term profitability,&#8221; Peng concluded.
Why It Matters: Recently, fund manager Gary Black, who has been a Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) bull for over a decade, called Pony a great option to &#8220;play future advances in global autonomy,&#8221; citing its <a href="https://www.benzinga.com/tech/25/05/45345942/gary-black-weighs-in-on-pony-ais-growth-ahead-of-earnings-report-a-recently-announced-partnership-with-uber">partnership with Uber</a> as the key reason behind the shift in sentiment. 
However, Black also cautions that the stock is &#8220;clearly overbought,&#8221; forecasting a correction over the next couple of weeks. 
The stock&#8217;s Relative Strength Index (RSI) is now at 61.32, which is &#8220;Neutral,&#8221; which essentially means that the stock is neither overbought nor oversold, and traders might wait for the RSI to exit this range before considering this stock again.
During its <a href="https://in.benzinga.com/news/earnings/25/05/45514486/chinas-pony-ai-robotaxi-revenue-jumps-200-eyes-1000-vehicle-fleet">first quarter results</a>, the company reported $14 million in revenue, up 11% year-over-year, with robotaxi revenues growing 200%, at $1.7 million, following significant expansion across major Chinese cities. Pony posted a loss of $0.10 per share, compared to a loss of $0.28 per share in the prior year quarter.
Price Action: The stock is down 3.30% on Wednesday, trading at $17.29 per share, and is down 1.62% after hours. This has been a volatile year, with a 315% rally since its low point in April, but it is still only up 13.82% year-to-date.
<figure class="wp-block-image aligncenter size-full is-resized"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="800" height="212" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21225050/Screenshot-2025-05-22-at-8.20.42-AM.png" alt="" class="wp-image-923700" style="width:475px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21225050/Screenshot-2025-05-22-at-8.20.42-AM.png 800w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21225050/Screenshot-2025-05-22-at-8.20.42-AM-300x80.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21225050/Screenshot-2025-05-22-at-8.20.42-AM-768x204.png 768w" sizes="(max-width: 800px) 100vw, 800px" /></a></figure>
According to Benzinga&#8217;s Edge Stock Rankings, Pony.ai has a favorable price trend in the short, medium, and long terms, but how does it compare with Tesla and Uber? Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> to find deeper insights. 
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45556622/larry-summers-asks-trump-to-retreat-on-taxes-just-like-he-did-on-tariffs-few-more-days-like-this-and-recession-will-be-likely">Larry Summers Asks Trump To &#8216;Retreat&#8217; On Taxes Just Like He Did On Tariffs: &#8216;Few More Days Like This And Recession Will Be Likely&#8217;</a></li>
</ul>
Photo courtesy: Michael Vi / Shutterstock.com

Travel

PONY

TSLA

UBER

Pony.ai Stock Is Up 315% In A Month As Uber Deal, Global Robotaxi Rollout, And Tariff Shield Fuel Investor Frenzy, But Can It Keep Up?

Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.82) by 73.17 percent. This is a 132.84 percent decrease over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $2.58 billion which beat the analyst consensus estimate of $2.50 billion by 3.37 percent. This is a 24.16 percent decrease over sales of $3.41 billion the same period last year.

Advance Auto Parts Q1 Adj. EPS $(0.22) Beats $(0.82) Estimate, Sales $2.58B Beat $2.50B Estimate

David Sacks, the&nbsp;top crypto and AI advisor&nbsp;to President Donald Trump, has projected that the impending stablecoin legislation could unlock trillions for the U.S. Treasury.
What Happened:&nbsp;Sacks expressed optimism about the bipartisan support for the stablecoin legislation currently being deliberated in the Senate. He suggested that establishing a legal framework for the already $200 billion worth of unregulated stablecoins could lead to a significant demand for U.S. Treasuries, according to a&nbsp;<a href="https://www.cnbc.com/2025/05/21/trump-crypto-czar-sacks-stablecoin-bill-unlock-trillions-for-treasury.html">CNBC report</a>&nbsp;on Wednesday.
If we provide the legal clarity and legal framework for this, I think we could create trillions of dollars of demand for our Treasuries practically overnight, very quickly,&#8221; stated Sacks.
The GENIUS Act, a bill designed to regulate stablecoins, has passed a crucial&nbsp;procedural vote in the Senate.&nbsp;With support from 15 Democrats, the bill has enough votes to overcome a filibuster. &#8220;We&nbsp;have every expectation now that&nbsp;it&#8217;s going to pass,&#8221; Sacks stated.
Sacks supports the GENIUS Act as a national economic strategy, highlighting stablecoins as a more efficient payment method that strengthens the dollar's online dominance. Meanwhile, the Trump family financially backs World Liberty Financial, which has launched a Treasury- and dollar-backed stablecoin called USD1.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/25/05/45539686/kevin-oleary-warns-trumps-big-beautiful-bill-could-be-devastating-for-small-businesses-somebodys-got-to-r" target="_blank" rel="noreferrer noopener">Kevin O&#8217;Leary Warns Trump&#8217;s &#8216;Big, Beautiful Bill&#8217; Could Be &#8216;Devastating&#8217; For Small Businesses: &#8216;Somebody&#8217;s Got To Raise The Red Flag&#8217;</a>
Why It Matters:&nbsp;Stablecoins, unlike other digital assets such as Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), have their value tied to real-world assets like the U.S. dollar.&nbsp;In the past year, Stablecoin transactions reached $28 trillion—exceeding the combined volume of Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) and Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>).
The push for stablecoin legislation has been gaining momentum for some time. In March 2025, President Trump called for stablecoin legislation at the Blockworks Digital Asset Summit, highlighting the potential of stablecoins to enhance the U.S. financial system and maintain the dollar&#8217;s global dominance. This marked his first address at a <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44420122/donald-trump-calls-for-stablecoin-legislation-lauds-bitcoin-reserve-biden-got-a-fraction-of-their-value">crypto conference</a> as a sitting president.
U.S. Sen. Bill Hagerty (R-Tenn.) stated that stablecoin issuers could become the<a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45516604/senator-hagerty-says-stablecoin-issuers-may-surpass-foreign-governments-in-us-treasury-holdings"> largest holders</a> of U.S. Treasuries globally by the end of the decade, citing projections from Citibank. He emphasized the role stablecoins play in transforming the payments landscape while underscoring their backing by short-term U.S. government debt.
Despite the optimism, the bill's passage faces hurdles. A contentious amendment from Sen. Josh Hawley (R-Mo.) could alienate banking supporters and potentially delay final approval.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/03/44450232/white-house-says-gold-reserves-may-be-used-to-purchase-bitcoin" target="_blank" rel="noreferrer noopener">White House Says Gold Reserves May Be Used to Purchase Bitcoin &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump's Crypto Czar David Sacks Foresees Stablecoin Bill Generating Trillions For US Treasury 'Practically Overnight'

Outlook
For the full year of 2025, the Company currently expects total net revenues to increase by 25% to 30% compared with the full year of 2024.
This outlook is based on current market conditions and the Company's preliminary estimates, which are subject to changes.

ATAT

CORRECTION: Atour Lifestyle Raises FY2025 Sales Guidance from $1.24B to $1.24B-$1.29B Vs. $1.26B Estimate

Needham analyst David Saxon reiterates Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) from Hold to Hold.

Needham Reiterates Hold on Cooper Companiesto Hold

As tariffs rattle retailers in the U.S., Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) is showing how years of quiet supply chain maneuvering can pay off.
What Happened: During its first-quarter earnings call on Wednesday, Target highlighted its commitment to keeping entry-level price points intact, even as it braces for widespread tariff-related impact on its margins and supply chain.
&#8220;We have many levers to use in mitigating the impact of tariffs, and price is the very last resort,&#8221; CEO Brian Cornell told investors.
The company&#8217;s efforts are most prominently visible at its Bullseye&#8217;s Playground storefront, where it sells a range of seasonal and trending items, with price points of $1, $3, and $5, which the company plans to hold firm on, despite tariff-related headwinds.
See Also: <a href="https://www.benzinga.com/25/05/45559653/steve-jobs-once-invited-marc-benioff-to-his-office-with-two-ipads-in-2010-the-lesson-that-shaped-a-270-billion-salesforce-empire">Steve Jobs Once Invited Marc Benioff To His Office With 2 iPads In 2010: The Lesson That Shaped A $270 Billion Salesforce Empire</a>
This is the result of years of effort by the company in reducing its reliance on Chinese imports. &#8220;Going back to 2017, we were 60% coming out of China. We brought that down to 30%, and we are well on our way to be less than 25% by the end of next year,&#8221; Chief Commercial Officer Rick Gomez said.
Target is now sourcing across Asia, the Western Hemisphere, and even domestically. &#8220;We're also exploring opportunities here in the U.S.,&#8221; Gomez said, noting the company is working closely with vendors to &#8220;provide the best value that we can for the consumer.&#8221;
Why It Matters: Analysts such as JPMorgan&#8217;s Christopher Horvers have raised concerns regarding the <a href="https://benzinga.com/25/05/45548732/target-under-strain-analyst-cautions-on-inventory-margins-amid-dei-and-tariff-issues">company&#8217;s rising inventory</a>, which rose 11% year-over-year, alongside weak same-store sales, and a miss on gross margin estimates during the first quarter.
This comes as the company&#8217;s chief rival, Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), <a href="https://www.benzinga.com/news/management/25/05/45473067/walmart-prices-will-rise-within-weeks-as-trump-tariffs-drive-up-costs-will-other-retailers-follow-suit">cautioned shoppers last week</a> that they could expect to see a rise in prices towards the end of May.
Price Action: Target shares were down 5.21% on Wednesday, trading at $93.01 per share, and down 0.35% after hours, following the company&#8217;s first quarter earnings results.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="136" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22060221/Screenshot-2025-05-22-at-3.32.10-PM-1024x136.png" alt="" class="wp-image-924109" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22060221/Screenshot-2025-05-22-at-3.32.10-PM-1024x136.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22060221/Screenshot-2025-05-22-at-3.32.10-PM-300x40.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22060221/Screenshot-2025-05-22-at-3.32.10-PM-768x102.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22060221/Screenshot-2025-05-22-at-3.32.10-PM-1536x205.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22060221/Screenshot-2025-05-22-at-3.32.10-PM.png 1592w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Target shares score well on Value and Growth, but are ranked poorly when it comes to Momentum and Quality. The price trend is unfavorable in the short, medium, and long terms. You can find deeper insights on the stock <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a>.
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45559682/why-urban-outfitters-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket">Why Urban Outfitters Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket</a></li>
</ul>
Photo courtesy: bluestork / Shutterstock.com

Equities

$1 Items, Made Outside China: Here's How Target Has Been Tariff-Proofing Its Shelves, With Price Hikes 'The Very Last Resort'

Needham analyst Mike Matson upgrades Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) from Hold to Buy and announces $12 price target.

Upgrades

INGN

Needham Upgrades Inogen to Buy, Announces $12 Price Target

Management

Press Releases

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World's Top Innovators

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer

CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update

CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE

CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates

JMP Securities

Leerink Partners

B of A Securities

SVB Securities

Comments

CureVac

Vendite allo scoperto

CureVac (NASDAQ:CVAC) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO